Work

Semaglutide, a glucagon like peptide-1 receptor agonist with cardiovascular benefits for management of type 2 diabetes

Year: 2022

Type: review

Source: Reviews in Endocrine and Metabolic Disorders

DOI: 10.1007/s11154-021-09699-1

Authors: Manoj Kumar Mahapatra, Muthukumar Karuppasamy, Biswa Mohan Sahoo

Institution: Roland Institute of Pharmaceutical Sciences

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4205983920

FWCI: 4.882

Cites: 76

Cited by: 191

Related to: 10